News Select Year All Years 2026 (21) 2025 (37) 2024 (31) 2023 (31) 2022 (35) 2021 (28) 2020 (36) 2019 (46) 2018 (51) 2017 (34) 2016 (26) 2015 (42) 2014 (30) 2013 (26) 2012 (23) 2011 (28) 2010 (36) 2009 (39) 2008 (55) 2007 (50) Clinical Trials Select Clinical Trial AWARE-1 (21) BRACELET-1 (10) GOBLET (35) Search … May 10, 2011 Oncolytics Biotech® Inc. Announces Phase I Multiple Myeloma Cancer Study May 5, 2011 Oncolytics Biotech® Inc. Announces Details of 2011 Annual Shareholder Meeting April 20, 2011 Oncolytics Biotech® Inc. Announces Positive Data from Translational Clinical Trial Investigating REOLYSIN® in Patients with Metastatic Colorectal Cancer March 31, 2011 MEDIA ADVISORY – Oncolytics Biotech® Inc. to Present at 10th Annual Needham Healthcare Conference March 24, 2011 Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN® in Combination with Paclitaxel and Carboplatin in Head and Neck Cancers March 3, 2011 MEDIA ADVISORY – Oncolytics Biotech® Inc. to Present at 31st Annual Cowen and Company Healthcare Conference March 1, 2011 Oncolytics Biotech® Inc. Receives $7.7 Million from Exercise of Warrants February 24, 2011 MEDIA ADVISORY – Oncolytics Biotech® Inc. to Present at RBC Capital Markets Healthcare Conference February 23, 2011 Oncolytics Biotech® Inc. Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN® in Patients with Metastatic Colorectal Cancer February 16, 2011 Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Pancreatic Cancer Study Newer Page 52 of 71 Older